TradingView
MarketMoversReport
Jun 8, 2022 6:00 PM
MediciNova Announces Positive Top-Line Results
Long
NASDAQ:MNOV
1D
MediciNova, Inc.
NASDAQ
Description
⋅
Jun 8, 2022 6:00 PM
MNOV: MediciNova, Inc.
2022-06-08 06:30:00
MediciNova Announces Positive Top-Line Results from Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute Respiratory Distress Syndrome
Beyond Technical Analysis
More